Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/24/2025

Discontinuing Bupropion While Maintaining Other Antidepressants

Monitoring and Follow-Up

  • The American Academy of Child and Adolescent Psychiatry recommends monitoring for return of depressive symptoms over several weeks following complete discontinuation of bupropion, as mood changes may not manifest immediately 1
  • The Journal of the American Academy of Child and Adolescent Psychiatry suggests that extended monitoring over weeks to months may be required to identify delayed symptom return after stopping bupropion 1

Treatment Strategy

  • The Mayo Clinic notes that maintaining duloxetine and trazodone provides continued antidepressant coverage and sleep support during the bupropion discontinuation, with duloxetine addressing serotonergic and noradrenergic pathways and trazodone managing sleep disturbances and providing additional serotonergic activity 2

Discontinuing Bupropion

Monitoring and Tapering Considerations

  • The American Academy of Child and Adolescent Psychiatry notes that increased suicidal ideation is a critical monitoring point, particularly in patients under 24 years old, during treatment rather than discontinuation 3
  • Energy level changes should be monitored, as bupropion has activating properties and patients may experience fatigue during withdrawal 3
  • The Mayo Clinic recommends that a slower taper is safer, but unnecessarily prolonged tapers can become the focus of patient anxiety 4

REFERENCES

1

practice parameter on the use of psychotropic medication in children and adolescents. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

3

Bupropion Dosing and Administration [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025